arrow
Z

Zhe Huang

Central South University
H指数:15
被引数:888

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PD-1/ PD-L1 bispecific antibody IBI318 combined with lenvatinib in advanced non-small cell lung cancer with acquired resistance to immune checkpoint inhibitors: a phase II trial

PD-1/PD-L1双特异性抗体IBI318联合仑伐替尼治疗对免疫检查点抑制剂获得性耐药的晚期非小细胞肺癌:一项II期临床试验

2025-12-150
OAAI
Efficacy and safety of finotonlimab plus docetaxel vs. docetaxel in previously treated advanced squamous cell non-small-cell lung cancer: a randomized, double-blinded, phase III trial

finotonlimab联合多西他赛对比多西他赛治疗既往经治的晚期鳞状细胞非小细胞肺癌的疗效与安全性:一项随机、双盲、III期临床试验

2025-04-010
OA